VBI (4170.TWO)
TWD 12.35
(-0.4%)
TWD 12.35
(-0.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -25.31 Million TWD | 9.17% |
| 2022 | -27.87 Million TWD | 28.89% |
| 2021 | -39.19 Million TWD | -36.29% |
| 2020 | -28.75 Million TWD | 69.74% |
| 2019 | -95.05 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -14.78 Million TWD | 0.0% |
| 2024 Q1 | -14.78 Million TWD | 41.58% |
| 2023 Q3 | -25.31 Million TWD | -3.58% |
| 2023 Q2 | -24.44 Million TWD | 0.0% |
| 2023 Q1 | -24.44 Million TWD | 12.31% |
| 2023 FY | -25.31 Million TWD | 9.17% |
| 2023 Q4 | -25.31 Million TWD | 0.0% |
| 2022 Q4 | -27.87 Million TWD | 0.0% |
| 2022 Q3 | -27.87 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 67.141% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 90.417% |
| Level Biotechnology Inc. | -453.9 Million TWD | 94.423% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 79.003% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 87.11% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 105.065% |
| GlycoNex Incorporation | -148.56 Million TWD | 82.96% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 162.872% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 118.346% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 90.359% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 182.792% |
| Visgeneer Inc. | 31.28 Million TWD | 180.923% |
| Mycenax Biotech Inc. | 207 Million TWD | 112.229% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 96.28% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 81.143% |
| Neith Corporation | -150.31 Million TWD | 83.158% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 104.073% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 56.093% |
| Enimmune corporation | -314.15 Million TWD | 91.942% |
| TaiRx, Inc. | -147.86 Million TWD | 82.879% |
| CHO Pharma, Inc. | -203.79 Million TWD | 87.578% |
| EirGenix Inc. | -4.58 Billion TWD | 99.448% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 70.133% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 120.945% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 99.213% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 92.024% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -27.775% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 179.588% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 149.879% |
| RBC Bioscience Corporation | 422.18 Million TWD | 105.996% |
| BiOptic Inc. | 12.59 Million TWD | 301.048% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 97.319% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 75.055% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 84.673% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 108.04% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 60.641% |
| NaviFUS Corp. | -123.12 Million TWD | 79.439% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 134.187% |
| Sinew Pharma Inc. | -160.34 Million TWD | 84.212% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 89.534% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 92.496% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 93.865% |
| AP Biosciences Inc | -196.52 Million TWD | 87.118% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 103.676% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -121.352% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 96.949% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 101.865% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 93.898% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 87.907% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 82.403% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 92.341% |
| TCI GENE Inc. | -689.25 Million TWD | 96.327% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 78.715% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 98.066% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 223.595% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 75.149% |
| PharmaEngine, Inc. | -860.8 Million TWD | 97.059% |
| Savior Lifetec Corporation | -812.54 Million TWD | 96.884% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 91.56% |
| OBI Pharma, Inc. | -398.22 Million TWD | 93.643% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 93.072% |
| Acepodia, Inc. | -6.02 Billion TWD | 99.579% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 99.256% |